NCT06948422: A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
- State
- Under way
- Phase
- Phase 3
- People
- 974 planned
- Started
- 30 Apr 2025
- Primary completion
- Sep 2027
- Arms
- Orforglipron (GZL1), Orforglipron (GZL2)
- Results
- None posted
- 29 Apr 2025: Trial registered
- 30 Apr 2025: Trial started